Oscar Health Inc vs Teradyne, Inc. — how do they compare? Oscar Health Inc trades at $28.9 (market cap $9.28B), while Teradyne, Inc. trades at $369.52 (market cap $58.55B). The key difference: Teradyne, Inc. is far larger — about 6.3× Oscar Health Inc's market cap, and Teradyne, Inc. pays a 0.14% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| OSCR | TER | |
|---|---|---|
Market Cap | $9.28B | $58.55B |
Sector | Health | Technology |
52-Week High | $32.18 | $483.84 |
52-Week Low | $10.85 | $90.15 |
Enterprise Value | $4.90B | $58.39B |
Dividend Yield | — | 0.14% |
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.
The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →